Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices: a Prospective, Paired, Self-controlled, Non-inferiority, Multicenter Clinical Trial

NCT06652750 is registered in ClinicalTrials.gov with The Third People's Hospital of Chengdu as lead sponsor.

NCT NCT06652750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06652750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices: a Prospective, Paired, Self-controlled, Non-inferiority, Multicenter Clinical Trial
Lead sponsor
The Third People's Hospital of Chengdu
Phase
Not applicable
Overall status
Recruiting
Start date
November 13, 2024
Completion date
February 1, 2026
Enrollment
688 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrioventricular block, second and third degree, heart failure, sick sinus syndrome